A phase II study of the efficacy of Compression therapy by using surgical gloves for prevention of nab-paclitaxel-induced peripheral neuropathy in primary and metastatic breast cancer patients.
- Conditions
- breast cancer
- Registration Number
- JPRN-UMIN000014064
- Lead Sponsor
- Kamigata Breast Cancer Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 40
Not provided
1) Multiple primary cancer. However, carcinoma in situ can be cured by local treatment is not included in multiple primary cancer. 2) Synchronous bilateral breast cancer. 3) Poorly controlled complication (infection, diabetes mellitus, and others). 4) Hypersensitivity to any agents necessary in the planned treatment. 5) Positive for HBs antigen. 6) Previous history of serious heart or lung disease 7) Peripheral sensory/motor neuropathy 8) Transfusion within 2 years 9) Previous history or receiving treatment of dementia or serious psychiatric disorder. 10) Large pleural effusion or ascites 11) Women who are pregnant, lactating or with childbearing potential. 12) Ineligible based on decision of an investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method